NCT04119427

Brief Summary

The safety and efficacy of micro-energy ultrasound in the treatment of renal insufficiency after renal transplantation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 2, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 8, 2019

Completed
7 months until next milestone

Study Start

First participant enrolled

May 1, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

May 12, 2020

Status Verified

October 1, 2019

Enrollment Period

1.7 years

First QC Date

October 2, 2019

Last Update Submit

May 9, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Measuring the patient'serum creatinine by a biochemical analyzer

    Measuring the patient'serum creatinine by a biochemical analyzer

    within 3 months after surgery

  • Manually record the patient's urine volume in 24 hours by a measuring glass

    Manually record the patient's urine volume in 24 hours by a measuring glass

    within 3 months after surgery

  • Measuring the patient'urea nitrogen by a biochemical analyzer

    Measuring the patient'urea nitrogen by a biochemical analyzer

    within 3 months after surgery

Secondary Outcomes (1)

  • Monitoring the blood flow of the transplanted kidney by a doppler ultrasound

    within 3 months after surgery

Study Arms (2)

Test Group

EXPERIMENTAL

After installing the disposable treatment head coat, the transplanted kidney was treated with an ultrasonic therapeutic apparatus; after the treatment, the disposable treatment head coat was removed. Patients were treated twice a week for 6 weeks.

Device: ultrasonic therapeutic apparatus 1

Control Group

PLACEBO COMPARATOR

The placebo was treated with an ultrasound therapy device and used in the same manner as the test group.

Device: ultrasonic therapeutic apparatus 2

Interventions

After installing the disposable treatment head coat, the transplanted kidney was treated with an ultrasonic therapeutic apparatus; after the treatment, the disposable treatment head coat was removed. Patients were treated twice a week for 6 weeks.

Test Group

The placebo was treated with an ultrasound therapy device and used in the same manner as the test group.

Control Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • More than half a year after renal transplantation, serum creatinine elevated over three times , patients with ineffective immunosuppressive drugs;
  • Mild to moderate renal insufficiency (creatinine less than 442umol / L);
  • Volunteer to participate in this clinical trial, comply with the requirements of this clinical trial and sign the informed consent form.

You may not qualify if:

  • Patients with severe renal insufficiency;
  • Blood routine suggests acute and chronic blood system diseases;
  • B-ultrasound suggests transplanting hydronephrosis;
  • Uncontrollable patients with diabetes, hypertension, and cardiovascular disease;
  • The investigator determined that it is not suitable for this clinical trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Second Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, 310009, China

RECRUITING

MeSH Terms

Conditions

Renal Insufficiency

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Central Study Contacts

Jiaquan Xiao, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 2, 2019

First Posted

October 8, 2019

Study Start

May 1, 2020

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

May 12, 2020

Record last verified: 2019-10

Locations